K.J. Harrison & Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

K.J. Harrison & Partners’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,860	Closed	-$5K	–	221
2020 Q1	$5K	Hold	12,860	–	–	﹤0.01%	134
2019 Q4	$5K	Buy	+12,860	New	+$21.4K	﹤0.01%	189

K.J. Harrison & Partners's CORV Position: Q2 2020 in Review

K.J. Harrison & Partners sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 12,860 shares — an estimated $5K sold.

K.J. Harrison & Partners first reported a position in CORV in Q4 2019 and held it in 2 quarters. The position peaked at $5K in Q1 2020. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

K.J. Harrison & Partners reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
K.J. Harrison & Partners sold 12,860 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $5K.
K.J. Harrison & Partners first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2019 and held it in 2 quarters.
K.J. Harrison & Partners's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $5K in Q1 2020.
0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on K.J. Harrison & Partners's 13F filing for Q2 2020, filed 3 Aug 2020.